Over the weeks of protests following the death of George Floyd, much attention has been given to a few viral posts that concern the number of hours of training that are required to obtain a ...
- PAION entitled to receive up to EUR 42.5 million in milestone payments and significant double-digit tiered royalties - PAION resolves issuance of 5,064,194 new shares to a subsidiary of Cosmo by way ...
Cosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX® 200mg in Europe, APAC, MENA and LATAM regions Dublin, Ireland – 4 September 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: ...
Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries
Dublin, Ireland – 02 October 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) and Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (“Hikma”) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback